Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 52 citing Redmon: One-year outcome of a combination of weight loss therapies for subjects with type 2 diabetes. (0.08 sec) 

Effect of sibutramine on weight management and metabolic control in type 2 diabetes


R Vettor, R Serra, R Fabris, C Pagano, G … - Diabetes Care, 2005 - Am Diabetes Assoc
RESULTS—Eight placebo-controlled, double-blind, randomized trials of
sibutramine were included. After sibutramine treatment, the decrease in body
weight and waist circumference was significantly greater than in the ...
Cited by 71 - Related articles - All 5 versions

A review of the metabolic effects of sibutramine


TD Filippatos, DN Kiortsis, EN Liberopoulos, … - Current Medical Research and Opinion®, 2005 - informahealthcare.com
(University of London), Royal Free Campus, London, UK Campus, London, UK ...
Address for correspondence: Professor Moses S. Elisaf, Department of Internal
Medicine, ses S. Elisaf, Department of In rtment of Internal Medic ment of ...
Cited by 62 - Related articles - All 11 versions

Orlistat is as beneficial as metformin in the treatment of polycystic ovarian syndrome

- endojournals.org
V Jayagopal, ES Kilpatrick, S Holding, PE … - Journal of Clinical Endocrinology & Metabolism, 2005 - Endocrine Soc
Twenty-one Caucasian women with PCOS [mean (±SEM) age 27 ± 0.9 yr and body
mass index 36.7 ± 3.3 kg/m 2 ] participated in this prospective, randomized,
open-labeled study. All subjects had an 8-wk run-in period of dietary ...
Cited by 56 - Related articles - BL Direct - All 8 versions

Weight-loss outcomes: a systematic review and meta-analysis of weight-loss clinical trials …

- anniebkay.com [PDF] 
MJ Franz, JJ VanWormer, AL Crain, JL … - Journal of the American Dietetic Association, 2007 - Elsevier
The primary outcomes were a measure of weight loss at 6, 12, 24, 36, and 48
months. Eight types of weight-loss interventions—diet alone, diet and
exercise, exercise alone, meal replacements, very-low-energy diets, ...
Cited by 46 - Related articles - All 4 versions

Cannabinoids and the regulation of ingestive behaviour


SP Vickers, GA Kennett - Current Drug Targets, 2005 - ingentaconnect.com
Abstract: Over past centuries, Cannabis sativa (∆ 9 -tetrahydrocannabinol
being the principal active ingredient) has been used extensively for both
medicinal and recreational uses, and one widely reported effect is the ...
Cited by 39 - Related articles - All 2 versions

Is roux-en-y gastric bypass surgery the most effective treatment for type 2 diabetes mellitus …

- metabolic-surgery.com [PDF] 
A Torquati, R Lutfi, N Abumrad, WO Richards - Journal of Gastrointestinal Surgery, 2005 - Springer
Type 2 diabetes mellitus (T2DM) has a very strong association with obesity. The
aim of our study was to analyze the effects of Roux-en-Y gastric bypass (RYGB)
surgery on the glucose metabolism in morbidly obese patients with T2DM. ...
Cited by 32 - Related articles - All 5 versions

Clinical pharmacotherapy for obesity: current drugs and those in advanced development

- d-lectable.com [PDF] 
JCG Halford - Current Drug Targets, 2004 - ingentaconnect.com
Abstract: The current obesity pandemic imposes a major global disease burden.
Levels of non-communicable diseases such as type 2 diabetes, cardiovascular
disease and some cancers will continue to rise unless an effective approach ...
Cited by 28 - Related articles - BL Direct - All 4 versions

Modulatory role of food, feeding regime and physical exercise on body weight and insulin …


BD Kretschmer, P Schelling, N Beier, C … - Life Sciences, 2005 - Elsevier
Energy intake and expenditure is a highly conserved and well-controlled system
with a bias toward energy intake. In times of abundant food supply, individuals
tend to overeat and in consequence to increase body weight, sometimes to ...
Cited by 29 - Related articles - All 4 versions

Two-year outcome of a combination of weight loss therapies for type 2 diabetes


JB Redmon, KP Reck, SK Raatz, JE Swanson, … - Diabetes Care, 2005 - Am Diabetes Assoc
RESEARCH DESIGN AND METHODS—A total of 59 overweight or obese individuals with
type 2 diabetes were randomly assigned to either a combination therapy weight
loss program for 2 years (C therapy) or a standard therapy weight loss ...
Cited by 24 - Related articles - All 11 versions

New approaches in the intensive management of cardiovascular risk in the metabolic …


RS Rosenson - Current Problems in Cardiology, 2005 - Elsevier
When risk factors such as dyslipidemia and hypertension are inadequately
controlled in subjects with the metabolic syndrome by lifestyle interventions,
pharmacologic approaches are warranted. Statins are first-line ...
Cited by 23 - Related articles - All 8 versions


Result Page: 

1

2

3

4

5

6

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google